The new proposed International Consensus Classification (ICC) classification incorporates ZNF384 rearrangement and myeloid/lymphoid neoplasm with eosinophilia (M/LN-eo) with tyrosine kinase (TK) gene fusions which can present as B/myeloid MPAL. The gene discussed is ZNF384; the disease is mixed phenotype acute leukemia.